HelenHeslopMDDSc (Hon)
Hematology • Houston, TXHematologic Oncology
Dan L. Duncan Chair, Baylor College of Medicine Director, Center for Cell and Gene Therapy Interim Director, Dan L Duncan Comprehensive Cancer Center Professor, Departments of Pediatrics and Medicine, and Center for Cell and Gene Therapy
Dr. Heslop is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6565 Fannin St
M964
Houston, TX 77030Phone+1 713-394-6250- Is this information wrong?
Education & Training
University of Otago School of MedicineClass of 1980
Certifications & Licensure
TX State Medical License 2001 - 2026
TN State Medical License 1992 - 2004
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs) Start of enrollment: 2000 Jan 01
- Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs). Start of enrollment: 2001 Jan 01
- Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL Start of enrollment: 1996 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsPosoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.Thomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu, Carlos Ramos, Ghadir Sasa, Caridad Martinez, Premal Lulla, Robert A Krance, Lauren Scherer, Daniel Ruderfer, Swati Naik...> ;Clinical Cancer Research. 2023 Jan 17
- 2 citationsReplication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained ...Kenneth Cornetta, Jing Yao, Kimberley House, Lisa Duffy, Prasad S Adusumilli, Rachel Beyer, Claire Booth, Malcolm Brenner, Kevin Curran, Bambi Grilley, Helen Heslop, C...> ;Molecular Therapy. 2023 Mar 1
- 2 citationsShould all CAR-T therapy for acute lymphoblastic leukemia Be consolidated with allogeneic stem cell transplant?Alejandro Marinos, Helen E Heslop> ;Best Practice & Research. Clinical Haematology. 2022 Dec 1
- Join now to see all
Journal Articles
- EBV/LMP-specific T Cells Maintain Remissions of T and B Cell EBV Lymphomas After Allogeneic Bone Marrow TransplantationStephen Gottschalk, Rayne Rouce, Catherine M Bollard, Malcolm K Brenner, Helen E Heslop, Blood
Abstracts/Posters
- Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell MalignanciesClinically Relevant AbstractHelen E. Heslop, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative DisordersHelen E. Heslop, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Incorporation of Thiotepa in a Reduced Intensity Conditioning Regimen Leads to Improved Engraftment after Stem Cell Transplant for Patients with Hemophagocytic Lymphoh...Helen E. Heslop, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Tessa Therapeutics, Baylor College of Medicine Execute Agreement for Global Commercial Rights to ‘Off-the-Shelf’ CAR-T PlatformNovember 7th, 2022- Dr. Pavan Reddy Named Director of Dan L Duncan Comprehensive Cancer CenterJune 2nd, 2022
- Baylor Creceives More Than $15.6 Million in CPRIT FundingFebruary 17th, 2022
- Join now to see all
Hospital Affiliations
Texas Children's HospitalHouston, Texas
Houston Methodist HospitalHouston, Texas
St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
